Azithromycin in viral infections
Azithromycin (AZM) is a synthetic macrolide antibiotic effective against a broad range of bacterial and mycobacterial infections. Due to an additional range of anti‐viral and anti‐inflammatory properties, it has been given to patients with the coronaviruses SARS‐CoV or MERS‐CoV. It is now being inve...
Auteurs principaux: | Oliver, ME, Hinks, TSC |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Wiley
2020
|
Documents similaires
-
Azithromycin for mild-to-moderate COVID-19 - Authors' reply
par: Hinks, TSC
Publié: (2021) -
Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment
par: Lavoie, G, et autres
Publié: (2024) -
Study of MAIT cell activation in viral infections in vivo
par: Hinks, TSC, et autres
Publié: (2019) -
Boosting MAIT cells as immunotherapy: Context is everything
par: Hinks, TSC
Publié: (2020) -
Azithromycin for mild-to-moderate COVID-19: author's reply
par: Hinks, TSC, et autres
Publié: (2021)